NCT00087386 2013-04-10Tanespimycin in Treating Patients With Stage III-IV MelanomaNational Cancer Institute (NCI)Phase 2 Terminated50 enrolled
NCT00627419 2012-12-10A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic MelanomaInfinity Pharmaceuticals, Inc.Phase 2 Terminated1 enrolled